キーワード検索結果
特定の雑誌をまとめてダウンロードすることは禁止しております。
海外ジャーナルレビュー
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
The Lancet Online first:Online first,2022
海外ジャーナルレビュー
Defibrillation Strategies for Refractory Ventricular Fibrillation
The New England Journal of Medicine Online first:Online first,2022
海外ジャーナルレビュー
Interventions and outcomes of multiple myeloma patients receiving salvage treatment after BCMA-directed CAR T therapy
Blood Online first:Online first,2022
海外ジャーナルレビュー
Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial
The Lancet 400:1704,2022
海外ジャーナルレビュー
Association of Intravenous Potassium and Magnesium Administration With Spontaneous Conversion of Atrial Fibrillation and Atrial Flutter in the Emergency Department
JAMA Network Open 5:e2237234,2022
海外ジャーナルレビュー
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
The Lancet 400:1788,2022
海外ジャーナルレビュー
Treatment Time and In-Hospital Mortality Among Patients With ST-Segment Elevation Myocardial Infarction, 2018-2021
The Journal of the American Medical Association 328:2033,2022
海外ジャーナルレビュー
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial
JAMA Cardiology Online first:Online first,2022
海外ジャーナルレビュー
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial
JAMA Oncology Online first:Online first,2022
海外ジャーナルレビュー
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer
Journal of Clinical Oncology 40:3383,2022
